A Phase I, Placebo-Controlled, Dose-Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of EGT0001442 In Healthy Japanese Volunteers and Subjects with Type 2 Diabetes Mellitus - A Phase I study for EGT0001442 in Healthy Japanese Volunteers and Subjects with Type 2 Diabetes Mellitus
100 Clinical Results associated with Integrated Development Associates Co., Ltd.
0 Patents (Medical) associated with Integrated Development Associates Co., Ltd.
100 Deals associated with Integrated Development Associates Co., Ltd.
100 Translational Medicine associated with Integrated Development Associates Co., Ltd.